Pre-Event
Monday, June 29th 2026
1:30PM – 7:00PM
From Antibody Discovery to IND: Advancing Biologics in Oncology
An Evotec science event held in conjunction with AIS 2026
Date: 29th June 2026 |Time: 13h30 until 19h00 CET
Antibodies and related modalities have transformed oncology through advances in engineering and a deeper understanding of cancer biology and immune surveillance. This event will feature invited lectures from internationally recognized leaders alongside Evotec experts covering integrated biologics discovery, antibody profiling, pharmacokinetics, and ADC strategies.
The half-day, science-focused event will take place ahead of the Antibody Industrial Symposium and provides an opportunity for in-depth scientific exchange and discussion.
Agenda
13h30
Registration and welcome coffee
14h05
OPENING KEYNOTE LECTURE
- Barthez Auditorium
Mining Antibody Biology for Novel Functionalities and Therapeutic Antibody Development
Janine Schuurman
Independent biotech Consultant
Lust for Life Science, Netherlands
14h35
INTRODUCTION
- Barthez Auditorium
Integrated Drug Discovery Continuum at Evotec
Francisco Cruzalegui
SVP Biology
EVOTEC
14h50
Early Antibody Discovery
- Barthez Auditorium
30 Years of Phage Display Supporting the Discovery of Meaningful Therapeutic Antibodies
Sophie Venet
Senior Research Scientist - In Vitro Biology
EVOTEC
Biophysical Interaction Mapping for Antibodies
Clémence Mondielli
Research Scientist - Biophysics
EVOTEC
De-Risking and Predicting the Behavior of Therapeutic Antibodies and Their Derivatives
Anne Larvor
Group Leader - Bioservices and Welfare
EVOTEC
15h45
Antibody-Drug Conjugates (ADCs) Drug Discovery
Christophe Boldron
VP - Head of Molecular Architects
EVOTEC
16h00
Coffe Break with pastries
16h30
Late Antibody Discovery
- Barthez Auditorium
Pharmacological Support for Antibody Discovery – Immune Synapse
Michael Esquerre
VP Immuno-Oncology - In Vitro Biology
EVOTEC
Humanized Mouse Models Supporting Antibody Profiling
Lise Pasquet
Senior Research Scientist - Immuno-Oncology In Vivo
EVOTEC
Production, Early Developability Assessment and Affinity Maturation in Antibody Drug Discovery
Ewa Pilka
Principal Scientist - Protein Production
EVOTEC
17h15
Just’s Molecular Design and Manufacturing Platform
Nick Hutchinson
Associate VP - Business Development
JUST - EVOTEC BIOLOGICS
17h30
CLOSING LECTURE
How Antibody-Based Therapies Were Game Changers in the Treatment of Patients With Hematologic Cancers
Prof. Guillaume Cartron
PU-PH - Head of the Clinical Hematology Department
Montpellier University Hospital, France
18h00
Cocktail reception and informal networking
